| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 14 | -480K | 100% | $84.11 | -$40.4M |
| Net | -14 | -480K | -100% | -$40.4M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Meridian Venture Partners II Lp | 10%+ Owner | $103M | Aug 16, 2023 | ||
| Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS, Director | $48M | -$17.9M | -27.2% | Aug 20, 2025 |
| Nikhil Lalwani | PRESIDENT & CEO, Director | $39.3M | -$6.84M | -14.8% | Aug 12, 2025 |
| Chad Gassert | Svp Corp. Dev. & Strategy | $21.8M | -$1.74M | -7.38% | Aug 15, 2025 |
| Stephen P. Carey | Svp & Cfo | $15.6M | -$4.72M | -23.3% | Aug 12, 2025 |
| James G. Marken | Svp Ops & Prod Dev | $7.98M | Jun 7, 2024 | ||
| Ori Gutwerg | Svp, Generics | $7.69M | -$884K | -10.3% | Aug 12, 2025 |
| Meredith Cook | Sr. Vp, General Counsel & Sec. | $6.8M | -$292K | -4.12% | Sep 12, 2025 |
| Christopher Mutz | Head Of Rare Disease | $6.49M | -$617K | -8.68% | May 14, 2025 |
| Patrick D. Walsh | Director | $6.24M | -$801K | -11.4% | Aug 15, 2025 |
| Krista Davis | Svp, Chief Hr Officer | $5.9M | -$561K | -8.68% | Sep 19, 2025 |
| Thomas Rowland | Svp, Head Established Brands | $3.5M | -$426K | -10.9% | Aug 12, 2025 |
| Thomas Haughey | Director | $3.14M | -$1.66M | -34.6% | Aug 12, 2025 |
| Robert E. Brown JR | Director | $2.77M | Apr 27, 2022 | ||
| David Nash | Director | $2.18M | May 23, 2023 | ||
| Antonio R. Pera | Director | $2.15M | -$1.18M | -35.4% | Sep 3, 2025 |
| Jeanne Thoma | Director | $2.08M | -$1.92M | -48% | Aug 18, 2025 |
| Renee Tannenbaum | Director | $1.88M | May 22, 2025 | ||
| Matthew J. Leonard | Director | $622K | -$841K | -57.5% | Aug 25, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|